Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.14/23062
Registo completo
Campo DCValorIdioma
degois.publication.titleJournal of Environmental Managementpt_PT
dc.contributor.authorBrazon, E. Marquez-
dc.contributor.authorPiccirillo, C.-
dc.contributor.authorMoreira, I. S.-
dc.contributor.authorCastro, P. M. L.-
dc.date.accessioned2017-10-12T17:31:40Z-
dc.date.available2017-10-12T17:31:40Z-
dc.date.issued2016-
dc.identifier.citationBRAZON, E. Marquez;, PICCIRILLO, C.; MOREIRA, I. S.; CASTRO, P. M. L. - Photodegradation of pharmaceutical persistent pollutants using hydroxyapatite-based materials. Journal of Environmental Management. ISSN 0301-4797. Vol. 182 (2016), p. 486-495pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.14/23062-
dc.description.abstractPharmaceutical persistent pollutants pose a serious threat to the environment. The aim of this study was to use, for the first time, hydroxyapatite-based biomaterials as photocatalysts to degrade micropollutants. Diclofenac and fluoxetine were selected for these initial tests. Hydroxyapatite (Ca10(PO4)(OH)2, HAp) is one of the most commonly used biomaterials/bioceramics, being a major constituent of bone. In this work sustainable HAp-based materials of marine origin, obtained from cod fish bones, were used; these photocatalysts were previously fully studied and characterised. Both singlephase HAp and HApetitania multicomponent materials (1 wt% TiO2) were employed as UV light photocatalysts, the latter showing better performance, indicated by higher degradation rates of both compounds. The HAp-titania photocatalyst showed excellent degradation of both persistent pollutants, the maximum degradation performance being 100% for fluoxetine and 92% for diclofenac, with pollutant and photocatalyst concentrations of 2 ppm and 4 g/L, respectively. Variations in features such as pollutant and photocatalyst concentrations were investigated, and results showed that generally fluoxetine was degraded more easily than diclofenac. The photocatalyst's crystallinity was not affected by the photodegradation reaction; indeed the material exhibited good photostability, as the degradation rate did not decrease when the material was reused. Tests were also performed using actual treated wastewater; the photocatalyst was still effective, even if with lower efficiency (-20% and -4% for diclofenac and fluoxetine, respectively). TOC analysis showed high but incomplete mineralisation of the pollutants (maximum 60% and 80% for DCF and FXT, respectively).pt_PT
dc.language.isoengpt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147263/PTpt_PT
dc.relationSFRH-BPD-86483-2012pt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F87251%2F2012/PTpt_PT
dc.rightsrestrictedAccesspt_PT
dc.subjectHydroxyapatitept_PT
dc.subjectPhotocatalysispt_PT
dc.subjectPersistent pollutantspt_PT
dc.subjectDiclofenacpt_PT
dc.subjectFluoxetinept_PT
dc.titlePhotodegradation of pharmaceutical persistent pollutants using hydroxyapatite-based materialspt_PT
dc.typearticlept_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.peerreviewedyespt_PT
dc.identifier.doihttp://dx.doi.org/10.1016/j.jenvman.2016.08.005pt_PT
Aparece nas colecções:CBQF - Artigos em revistas internacionais com Arbitragem / Papers in international journals with Peer-review



FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.